Heather Shappell

Association of Lonafarnib Treatment vs No Treatment With Mortality Rate in Patients With Hutchinson-Gilford Progeria Syndrome

Leslie B. Gordon, Heather Shappell, Ralph B. D’Agostino et al. · JAMA · 2018 · 220 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome

Leslie B. Gordon, Monica E. Kleinman, Ralph B. D’Agostino et al. · Circulation · 2016 · 154 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

What Would You Do? Specialists’ Perspectives on Cancer Genetic Testing, Prophylactic Surgery, and Insurance Discrimination

Ellen Matloff, Heather Shappell, Karina L. Brierley et al. · Journal of Clinical Oncology · 2000 · 112 citations

Life Sciences, Genetics, Oncology +17

Improved state change estimation in dynamic functional connectivity using hidden semi-Markov models

Heather M. Shappell, Brian Caffo, James J. Pekar et al. · NeuroImage · 2019 · 86 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

Children with attention-deficit/hyperactivity disorder spend more time in hyperconnected network states and less time in segregated network states as revealed by dynamic connectivity analysis

Heather M. Shappell, Kelly A. Duffy, Keri S. Rosch et al. · NeuroImage · 2021 · 65 citations · Full text

Life Sciences, Neuroscience, Psychiatry +17